Antibody fragment (sdAb) 2

[{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f957285/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f957285/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f957286/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f957286/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f957287/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f957287/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f957288/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f957288/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f957289/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f957289/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f95728a/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f95728a/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f95728b/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f95728b/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f95728c/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f95728c/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f95728d/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f95728d/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f95728e/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f95728e/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f95728f/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f95728f/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f957290/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f957290/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f957291/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f957291/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f957292/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f957292/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f957293/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f957293/6679920e666b6a652f9564f2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6679ae76666b6a652f957294/6679920e666b6a652f9564f2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6679ae76666b6a652f957294/6679920e666b6a652f9564f2.png"}]